• OPEN AN ACCOUNT
Indian Indices
Nifty
25,003.05 252.15
(1.02%)
Sensex
82,188.99 746.95
( 0.92%)
Bank Nifty
56,578.40 817.55
( 1.47%)
Nifty IT
37,294.85 186.90
( 0.50%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,837.91 26.87
(0.30%)
Forex
USD-INR
85.85 0.27
(0.32%)
EUR-INR
97.86 0.31
(0.32%)
GBP-INR
116.24 0.53
(0.46%)
JPY-INR
0.60 0.00
(0.24%)

EQUITY - MARKET SCREENER

Themis Medicare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
530199
INE083B01024
31.1725595
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
THEMISMED
52.1
1246.68
EPS(TTM)
Face Value()
Div & Yield %
2.6
1
0
 

Redtape drops after Q4 PAT slides 43% QoQ
May 28,2025
Profit before tax (PBT) stood at Rs 57.70 crore in Q4 FY25, down 41.71% quarter-on-quarter, but up 6.28% year-on-year.

The company's consolidated net profit rose 1.25% while net sales declined 0.32% in Q4 March 2025 over Q4 March 2024.

For the full year, net profit fell 3.40% to Rs 170.24 crore while net sales increased 9.28% to Rs 2,020.18 crore in the year ended March 2025 over the year ended March 2024. PBT fell 1.32% year-on-year to Rs 233.12 crore in FY25 over FY24.

The company's consolidated net cash from operating activities stood at Rs 13.96 crore in FY25, lower than Rs 84.37 crore in FY24.

Redtape is engaged in the business of retail sale of footwear, garments & apparels and allied products and is also a manufacturer of footwear.